期刊文献+

脑动脉选择性亚低温治疗缺血性卒中的研究进展 被引量:10

下载PDF
导出
摘要 溶栓是唯一被证实治疗卒中有效的方法,但由于该方法对治疗时间窗及入选标准的严格限制,临床上仅有极少患者可在发病4.5h内接受重组组织型纤溶酶原激活剂(rt.PA)的治疗。亚低温治疗是通过物理或药物治疗的方法将人体全身或局部温度降低至目标值,从而产生治疗或保护功效。
出处 《中国脑血管病杂志》 CAS CSCD 北大核心 2017年第3期155-158,共4页 Chinese Journal of Cerebrovascular Diseases
基金 国家自然科学基金(81500997)
  • 相关文献

参考文献2

二级参考文献18

  • 1董强.解读重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中临床应用共识[J].中华内科杂志,2006,45(12):1046-1047. 被引量:5
  • 2Lees KR, Bluhmki E, von Kummer K, Brott TG, Toni D, GrottaJC, A1 hers GW, Kaste M. Marler JR, Hamilton SA, Tilley BC,Davis SM. Donnan GA. Hatke W; FXASS. ATLANTIS, NINDSand EPITHET rt-PA Study Group; Allen K, Mau J, Meier D,del Zoppo G, !)e Silva DA, Butcher KS, Parsons MW, BarberPA. I.evi C, Bladin C, Byrnes G. Time lo treatment withintravenous allfplase ami outconit* in stroke: an updated pooledanalysis of ECASS, ATLANTIS, NINDS. and EPITHET trials.Lancet. 2010, 375:1695-1703.
  • 3Hackt* W. Kaste M, H1 u h m k i E, Brozman M, Devalos A,Guidetti D, Larrue V, Lees KK, Medeghri Z, Machnig T,Schneider I), von Kummer H. Wahlgren N. Toni D.Thromliolysis with alteplase 3 to 4.5 hours after acule ischemicstroke. N Engl J Med, 2008. 359:1317-1329.
  • 4Meretoja A. Putaala J. Tatlisumuk T, Alula S, Arlto V,.CurtzeS, Happolil 0, Lindsberg PJ, Mustanoja S, Piironen K,Pitkaniemi J, Rantanen K. Sairanen T, Salonen 0. SilvennoinenH, Soinne L, Strbian D, Tiainen M. Kaste M. Off - labelthrombolysis is not associated with poor outcome in patientswith stroke. Stroke, 2010, 41:1450-1458.
  • 5Lou M. Safdar A. Mehdiralta M, Kumar S, Schlaug G, CaplanL. Searls I). Selim M. The HAT Score: a simple grading scalefor predicting hemorrhage after thrombolysis. Neurology, 2008,71:1417-1423.
  • 6Strhian 0, Engeller S. Michel P, Meretoja A. Sekoranja L,Ahlhelni KJ, Muslanoja S. Kuzmanovic I,Sairanen T, Forss N,Cordier M, I.yrer P, Kaste M, Tatlisumak T. Symptomaticintracranial hemorrhage after stroke thrombolysis: ihe SEDANscore. Ann Neurol. 2012, 71:634-641.
  • 7Sharma VK, Ng KW, Venketasuhramanian N, Teoh HL, ChanBP. Intravenous thrombolysis for acute ischemic stroke in Asia.Expert Rev Neurother, 2012, 12:209-217.
  • 8Padma MV, Singh MB, Bhatia K, Srivastava A, Tripathi M,Shukla G,Goyul V, Singh S, Prasad K. Behari M.llyperacutethrombolysis with iv rtPA of acutt* ischemic stroke: efficacy andsafety profile of 54 patients at a tertiary referral center in adeveloping country. Neurol India, 2007. 55:46-49.
  • 9Larrue V, von Kummer R, del Zoppo G, Bluhmki E.Hemorrhagic transformation in acute ischemic stroke: potentialcontributing factors in the European Cooperative Acute StrokeStudy. Stroke, 1997, 28:957-960.
  • 10Larrue V, von Kummer RR. Miiller A, Bluhmki E. Risk factorsfor severe hemorrhagic transformation in ischemic strokepatients treated with recom})inant tissue plasminogen activator:a secondary analysis of the European-Australasian Acule StrokeStudy (ECASS II). Stroke, 2001,32:438-441.

共引文献120

同被引文献126

引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部